alpha pharma retatrutide Triple Agonist (GLP-1/GIP/GCG) Retatrutide 10mg/vial - Koru iPharma

Coskun T, Sloop KW, Loghin C, Alsina-Fernandez J, Urva S, Bokvist KB, Cui X, Briere DA, Cabrera O, Roell WC, Kuchibhotla U, Moyers JS, Benson CT, Gimeno RE, DAlessio DA, Haupt A (2018) LY3298176, a novel dual GIP and GLP-1 receptor agonist for the treatment of type 2 diabetes mellitus: from discovery to clinical proof of concept

Businesses are changing prescriptions, mixing in additives, or encouraging stockpiling of existing compounded products

10.1146/annurev-med-043021-014919 [DOI] [PubMed] [Google Scholar] 75

The question of whether this translates directly to humans is still being studied, but the neuroanatomical overlap is significant

The transduction ratio (tau/Ka) was extracted from standard concentration-response data that was analysed with the operational model of agonism (Kenakin & Christopoulos 2012)